These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 3596983)
1. Correlation of fibrinolytic activity with invasion and metastasis of R3230 AC rat mammary carcinoma cell lines. Pauli BU; Kellen JA; Ng R Invasion Metastasis; 1987; 7(3):158-71. PubMed ID: 3596983 [TBL] [Abstract][Full Text] [Related]
2. Single-chain, urokinase-type plasminogen activator in a tumor model linked to metastatic potential. Kellen JA; Mirakian A; Wong A In Vivo; 1988; 2(2):155-7. PubMed ID: 2979833 [TBL] [Abstract][Full Text] [Related]
3. Enhanced plasminogen activator production by highly metastatic variant cell lines of a rat mammary adenocarcinoma. Ramshaw IA; Badenoch-Jones P; Grant A; Maxted M; Claudianos C Invasion Metastasis; 1986; 6(3):133-44. PubMed ID: 3733365 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen activators as markers of tumor colonization potential. Ng R; Kellen JA; Wong AC Invasion Metastasis; 1983; 3(4):243-8. PubMed ID: 6689573 [TBL] [Abstract][Full Text] [Related]
5. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Nakajima M; Welch DR; Belloni PN; Nicolson GL Cancer Res; 1987 Sep; 47(18):4869-76. PubMed ID: 3621180 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 'spontaneous' and 'experimental' metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Welch DR; Neri A; Nicolson GL Invasion Metastasis; 1983; 3(2):65-80. PubMed ID: 6677622 [TBL] [Abstract][Full Text] [Related]
7. Lectin resistance and lectin binding in a rat adenocarcinoma. Ng R; Kellen JA Anticancer Res; 1983; 3(6):421-3. PubMed ID: 6689469 [TBL] [Abstract][Full Text] [Related]
8. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. Neri A; Welch D; Kawaguchi T; Nicolson GL J Natl Cancer Inst; 1982 Mar; 68(3):507-17. PubMed ID: 6950180 [TBL] [Abstract][Full Text] [Related]
9. Suppression of pulmonary metastases of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor. Evans DM; Lin PL Am Surg; 1995 Aug; 61(8):692-6; discussion 696-7. PubMed ID: 7618808 [TBL] [Abstract][Full Text] [Related]
10. Involvement of plasminogen activator production with tumor metastasis in a rat model. Carlsen SA; Ramshaw IA; Warrington RC Cancer Res; 1984 Jul; 44(7):3012-6. PubMed ID: 6539167 [TBL] [Abstract][Full Text] [Related]
11. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87). Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639 [TBL] [Abstract][Full Text] [Related]
12. Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones. Welch DR; Aeed PA; Earhart RH; McClure SA Anticancer Res; 1994; 14(5A):1743-51. PubMed ID: 7847807 [TBL] [Abstract][Full Text] [Related]
13. Antimetastatic effect of amiloride in an animal tumour model. Kellen JA; Mirakian A; Kolin A Anticancer Res; 1988; 8(6):1373-6. PubMed ID: 3218971 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model. Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966 [TBL] [Abstract][Full Text] [Related]
15. Spontaneous capillary tube migration of metastatic rat mammary adenocarcinoma cells. Badenoch-Jones P; Ramshaw IA Invasion Metastasis; 1984; 4(2):98-110. PubMed ID: 6539758 [TBL] [Abstract][Full Text] [Related]
17. Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines. Davies BR; Barraclough R; Rudland PS Cancer Res; 1994 May; 54(10):2785-93. PubMed ID: 8168111 [TBL] [Abstract][Full Text] [Related]
18. Selection of highly metastatic rat MTLn2 mammary adenocarcinoma cell variants using in vitro growth response to transferrin. Cavanaugh PG; Nicolson GL J Cell Physiol; 1998 Jan; 174(1):48-57. PubMed ID: 9397155 [TBL] [Abstract][Full Text] [Related]
19. Fibrin formation induced by tumor procoagulants enhances urokinase activity produced by mammary carcinoma cells. Alonso DF; De Lorenzo MS; Tejera AM; Gomez DE Oncol Rep; 1998; 5(1):209-12. PubMed ID: 9458324 [TBL] [Abstract][Full Text] [Related]